These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37765308)

  • 1. A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines.
    Banche Niclot AGS; Marini E; Ferrero I; Barbero F; Rosso E; Fenoglio I; Barge A; Pessina A; Coccè V; Paino F; Mareschi K; Fagioli F
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel.
    Coccè V; Franzè S; Brini AT; Giannì AB; Pascucci L; Ciusani E; Alessandri G; Farronato G; Cavicchini L; Sordi V; Paroni R; Dei Cas M; Cilurzo F; Pessina A
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30717104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome.
    Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Temporomandibular Joint Osteoarthritis by Dental Stem Cell Secretome.
    Bousnaki M; Bakopoulou A; Grivas I; Bekiari C; Pich A; Rizk M; Keklikoglou K; Papachristou E; Papadopoulos GC; Kritis A; Mikos AG; Koidis P
    Stem Cell Rev Rep; 2023 Nov; 19(8):2957-2979. PubMed ID: 37751010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy.
    Kalimuthu S; Gangadaran P; Rajendran RL; Zhu L; Oh JM; Lee HW; Gopal A; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Pharmacol; 2018; 9():1116. PubMed ID: 30319428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC).
    Cordani N; Lisini D; Coccè V; Paglia G; Meanti R; Cerrito MG; Tettamanti P; Bonaffini L; Paino F; Alessandri G; Marcianti A; Giannì A; Villa C; Mauri M; Mologni L; Torsello A; Pessina A; Cazzaniga ME
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells alleviate paclitaxel-induced mechanical allodynia in rats.
    Sezer G; Yay AH; Sarica ZS; Gonen ZB; Onder GO; Alan A; Yilmaz S; Saraymen B; Bahar D
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23207. PubMed ID: 36052563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green synthesis, formulation and biological evaluation of a novel ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line.
    Akbarian M; Mahjoub S; Elahi SM; Zabihi E; Tashakkorian H
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110686. PubMed ID: 31816463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma.
    Wang M; Lv CY; Li SA; Wang JK; Luo WZ; Zhao PC; Liu XY; Wang ZM; Jiao Y; Sun HW; Zhao Y; Zhang P
    J Nanobiotechnology; 2021 Jul; 19(1):210. PubMed ID: 34261493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.
    Mannerström B; Kornilov R; Abu-Shahba AG; Chowdhury IM; Sinha S; Seppänen-Kaijansinkko R; Kaur S
    Epigenetics; 2019 Apr; 14(4):352-364. PubMed ID: 30907225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
    Foglietta F; Spagnoli GC; Muraro MG; Ballestri M; Guerrini A; Ferroni C; Aluigi A; Sotgiu G; Varchi G
    Int J Nanomedicine; 2018; 13():4847-4867. PubMed ID: 30214193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
    Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
    Front Immunol; 2022; 13():960909. PubMed ID: 36052081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.